Media Affairs is USU's official link to local, national and international media organizations. Our staff members help generate widespread media interest in USU's programs, people and achievements by reaching out to news organizations worldwide.

Media Affairs also provides consultation services to members of our campus community. This training helps maximize the positive, wide-spread media attention our faculty, staff and students often receive from major news outlets across the globe.




Researchers awarded up to $24 million to develop vaccines and therapies for highly pathogenic Nipah and Hendra viruses (pdf)

Bethesda, Md. – Uniformed Services University of the Health Sciences (USU), along with Profectus Biosciences, Inc., the Vanderbilt University Medical Center, Mapp Biopharmaceutical, Inc., and the University of Texas Medical Branch (UTMB), have been awarded up to $24.5 million to advance treatments for the highly lethal henipaviruses, Nipah and Hendra.


New Study Links ‘Mastermind’ Gene to Rare Cancer-Causing Tumor (pdf)

Bethesda, MD – Scientists have discovered a new “mastermind fusion gene” may be associated with a rare cancer-causing tumor – pheochromocytomas (“pheo”) and paragangliomas, according to a study published Feb. 13 in Cancer Cell, by researchers at Uniformed Services University (USU) and the National Cancer Institutes’ The Cancer Genome Atlas. This breakthrough discovery could lead to more precise treatment as well as a better understanding of cancer itself.


USU Researchers to support NIAID in US-Liberia Ebola Clinical Trial Partnership Initial study will evaluate experimental drug cocktail ZMapp (pdf)

Bethesda, MD -- A new clinical trial to obtain safety and efficacy data on the investigational drug, ZMapp, as a treatment for the Ebola virus, was launched today by the National Institute of Allergy and Infectious Diseases (NIAID), in partnership with the Liberian government. Scientists from Uniformed Services University of the Health Sciences (USU) will play a role in the evaluation.